Daily News

Most Recent

UK virus outbreak likely due to Surrey labs

By | August 8, 2007

Govt. report links foot-and-mouth outbreak to labs researching and producing vaccines

1 Comment

Former UPenn postdoc faked images

By | August 7, 2007

Nineteen manipulated images prompted two retractions, according to ORI

3 Comments

Fabricated stem cell line origin revealed

By | August 2, 2007

Woo-suk Hwang et al.'s original embryonic stem cell line derived from parthenogenesis, new study confirms

2 Comments

Edward Boyse dies

By | August 1, 2007

Arizona researcher uncovered basic principles of immune response

0 Comments

Geneticist new State Dept. advisor

By | August 1, 2007

Nina Fedoroff will promote science in foreign policy

1 Comment

Cartooning science misuses

By | July 31, 2007

Union of Concerned Scientists online visitors pick their favorite cartoon to headline a 2008 calendar

7 Comments

Discrimination in academia

By | July 31, 2007

See what other readers had to say about the decision of a faculty member and administrator to resign over conditions at MIT

42 Comments

Doubts over UK research head

By | July 31, 2007

Parliamentary committee questions MRC chair's leadership

0 Comments

Gene therapy trial on hold

By | July 31, 2007

Researchers say viral vector unlikely to be culprit in patient's death

1 Comment

Regulators evolve faster than genes

By | July 31, 2007

Mutations in regulatory sequences may be the main drivers of species divergence

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. Does Productivity Diminish Research Quality?
  3. How Plants Evolved Different Ways to Make Caffeine
  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech